← Open Payments lookup

HANNAH RAY: Open Payments

NPI 1972287415 · CONWAY, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,111 in 46 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $334 · 2025 $1,111

Food & beverage: $1,111
CompanyPaymentsAmount
Actelion Pharmaceuticals US, Inc.10$349
GlaxoSmithKline, LLC.7$162
Boehringer Ingelheim Pharmaceuticals, Inc.4$78
Takeda Pharmaceuticals U.S.A., Inc.3$66
GENZYME CORPORATION3$63
AstraZeneca Pharmaceuticals LP3$59
Averitas Pharma Inc.2$57
Corcept Therapeutics2$48
Regeneron Healthcare Solutions, Inc.2$45
Tandem Diabetes Care, Inc.3$32

Products named: UPTRAVI, OPSUMIT, NUCALA, DUPIXENT, GLASSIA, QUTENZA, Korlym, OFEV.

Industry payments across AR — which companies pay providers there.